1Albain K S,Nag S,Calderillo Ruiz G,et al.Global phaseⅢstudy of gemcitabine plus paclitaxel(GT)vs.paclitaxel(T)as frontline therapy for metastatic breast cancer(MBC);first report of overall survival[].Journal of Clinical Oncology.2004
23rd,Burris,HA.Single-agent docetaxel (Taxotere) in randomized phase III trials[].Seminars in Oncology.1999
3BuzdarA,Douma J,DavidsonN,et al.Phase HI,multicenter,dou-ble-blind.randomized study of letrozole,an aromatase inhibitor,for advanced breast cancer versus megestrol acetate[].Journal of Clinical Oncology.2001
4Jones S,Erban J,Overemoyer B,et al.Randomized trial comparing docetaxel and paclitaxel in patients with metastatic breast cancer[].Breast Cancer Research.2004
5Lin NU,CareyLA,LiuMC, etal.Phase II trialof lapatinib for brainmetastases in patients with HER2+ breast cancer[ J][].Journal of Clinical Oncology.2006
6Mouridsen H,Gershanovich M,Sun Y,et al.Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group[].Journal of Clinical Oncology.2001
7Vogel CL,Cobleigh MA,Tripathy D,et al.Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer[].Journal of Clinical Oncology.2002
8Paridaens R,Biganzoli L,Bruning P,et al.Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European Organization for Research and Treatment of Cancer Randomized Study with cross-over[].Journal of Clinical Oncology.2000
9Sledge GW,Neuberg D,Bernardo P,et al.Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193)[].Journal of Clinical Oncology.2003
10O’Shaughnessy J,Miles D,Vukelja S,et al.Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase Ⅲ trial results[].Journal of Clinical Oncology.2002
10Sennoune SR,Bakunts K,Martínez GM,et al.Vacuolar H^+-ATPase in human breast cancer cells with distinct metastatic potential:distribution and functional activity[J].Am J Physiol Cell Physiol,2004,286(6):C1443-1452.
